Abstract:In recent years, adult stem cells isolated from postnatal tissues have aroused tremendous interest as to their potential applications in human regenerative medicine [1]. The overwhelming majority of studies in animal models and phase I human clinical trials have focused on the transplantation of relatively uncommitted or undifferentiated adult stem cells. This has disadvantages that could reduce the efficacy of tissue/organ regeneration by the transplanted cells. Undifferentiated or uncommitted adult stem cells obviously lack expression of specific cell-surface markers that could facilitate their rapid engraftment and integration within the recipient tissue or organ, ie, gap-junction connexin proteins, surface ligands for interaction with extracellular matrix. Further complications may arise from the pathological state of damaged or diseased tissues/organs providing an abnormal milieu for the differentiation of the transplanted adult stem cells. The presence of necrotic/apoptotic cells, free radicals, and inflammatory cytokines within the pathological environment may exert an adverse effect on the differentiation pathway of the transplanted adult stem cells. This could reduce the proportion of transplanted cells giving rise to the required lineage of interest, as well as result in the formation of undesired tissue lineages at the transplantation site, which could impair tissue/organ regeneration. Thus, in a study by Wang et al [2], transplantation of undifferentiated mesenchymal stem cells into the pathological environment of damaged cardiac muscles resulted in differentiation of some of these cells into fibroblastic scar tissue, which could impair the subsequent recovery of cardiac function after myocardial infarction. A possible solution to these problems would be to direct adult stem cell commitment or differentiation into specific lineages prior to transplantation in situ. This may be achieved by exposing adult stem cells to exogenous cytokines, growth factors, chemicals, or extracellular matrix substratum during prolonged in vitro culture [3]. However, this has disadvantages if autologous cells are to be utilized for transplantation therapy. Obviously, this would delay treatment of the patient, who is likely to be in dire need of therapeutic intervention. There is also evidence that prolonged duration of ex vivo culture can somehow alter the immunogenicity of cultured autologous cells, which may lead to immuno-rejection following transplantation [4-6]. Adult stem cells in the pathway of terminal differentiation may have reduced proliferative potential, which could reduce their ability to contribute to tissue/organ regeneration. Hence, differentiated derivatives of autologous adult stem cells that arise from prolonged ex vivo culture may not be ideal for cell-transplantation therapy. Genetic modulation with recombinant DNA technology could potentially offer a rapid and efficient means of directing autologous adult stem

Isolation and efficient expansion of multipotent adult stem cells derived from the elderly skin

[Isolation and Differentiation Characteristics of Dermal Multipotent Stem Cells from Humans of Different Ages Cultured in Vitro].

Ex Vivo Expansion and Pluripotential Differentiation of Cryopreserved Human Bone Marrow Mesenchymal Stem Cells

Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies

Ex Vivo Expansion and Pluripotential Differentiation of Cryopreserved Bone Marrow Mesenchymal Stem Cells

Isolation, culture and identification of adult epidermal stem cell]

Ex Vivo Expansion, Adipogenesis And Neurogenesis Of Cyropreserved Human Bone Marrow Mesenchymal Stem Cells

Partial Cellular Reprogramming Stably Restores the Stemness of Senescent Epidermal Stem Cells.

Stabilization of cellular properties and differentiation mutilpotential of human mesenchymal stem cells transduced with hTERT gene in a long-term culture.

Long-term Culture and Differentiation of Skin-derived Mesenchymal Stem Cells

Reprogramming of Aged Cells into Pluripotent Stem Cells by Nuclear Transfer

Stem cells immortalized by hTERT perform differently from those immortalized by SV40LT in proliferation, differentiation, and reconstruction of matrix microenvironment

Factors Influencing the Successful Isolation and Expansion of Aging Human Mesenchymal Stem Cells

Aging of Human Adult Stem Cells.

Establishment of an Induced Pluripotent Stem Cell Line (Csui003-A) from Fibroblasts of a Healthy Elderly Individual

Autologous adult cardiac stem cells amplification efficiency and specific identification in vitro

Large-scale expansion of clinical-grade human adipose-derived stem cells using the extracellular matrix

Potential Benefits of Co-Transplanting Autologous Adult Stem Cells Together with Human Embryonic Stem Cells or Their Differentiated Derivatives.

Effects of Age on Biological and Functional Characterization of Adipose-Derived Stem Cells from Patients with End-Stage Liver Disease

Embryonic Stem Cells: New Possible Therapy for Degenerative Diseases That Affect Elderly People.

Possibility to use iPS-technology in age-related diseases